About Michael Liang
Form D filings for Alto Neuroscience in 2023 list Michael Liang as director.
Michael Liang first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Liang in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Liang works with at each company, as listed on that company's latest Form D.
Alto Neuroscience, Inc. · Form D, Nov 27, 2023
Chris Dimitropoulos
Director
CC
Christopher Cox
Director
AW
Aaron Weaver
Director
AD
Andrew Dreyfus
Director
NS
Nicholas Smith
Executive officer
GY
Gwill York
Director
AS
Adam Savitz
Executive officer
PC
Po Yu (Jeff) Chen
Director
AE
Amit Etkin
Chief Executive Officer and director